Emerging Managers
161 stories covering emerging managers — fund closes, LP allocations, regulatory filings, deal flow, and fundraising signals from PipelineRoad's editorial team.
Investment Solutions Tacora Credit 2025 Access Fund LP Files Under Investment Company Act
Investment Solutions Tacora Credit 2025 Access Fund LP filed a document with SEC EDGAR on March 19, 2026, citing Section 3(c) and Section 3(c)(7) of the Investment Company Act.
GSV Credit Fund I, LP Files SEC Document
Emerging fund manager GSV Credit Fund I, LP submitted a filing to the SEC on March 18, 2026, as per official records.
Origin Select Asset Fund Files Under Investment Company Act Section 3(c)
D - Origin Select Asset Fund, LLC filed a document with SEC EDGAR on March 18, 2026, referencing Investment Company Act Sections 3(c) and 3(c)(5).
Boreal Ventures Closes $43M for Fund II, Targeting $60M
Canadian firm Boreal Ventures has closed its second fund at $43 million while aiming for $60 million, with returning LPs from its debut fund.
Deep Ventures Capital Fund I, LP Files SEC Document on Investment Company Act
Deep Ventures Capital Fund I, LP submitted a filing to the SEC on March 18, 2026, related to Section 3(c)(1) of the Investment Company Act.
Water Street Partners Ltd Files SEC Document for Section 3(c)(1)
Water Street Partners Ltd submitted a SEC filing on March 18, 2026, related to Section 3(c)(1) of the Investment Company Act.
Synergy Asia Market Neutral Fund Files Under Section 3(c)(1)
Synergy Asia Market Neutral Fund submitted a SEC filing on March 18, 2026, under Investment Company Act Section 3(c)(1), as reported in SEC EDGAR records.
Breakout Ventures' Fishburne on LPs Valuing Consistency
Breakout Ventures' managing partner Lindy Fishburne discusses how maintaining focus appeals to LPs amid market shifts in venture funds.
Star Capital Aims for €300m Raise in Vincorion IPO on Frankfurt Exchange
Star Capital plans to raise €300m through the IPO of Vincorion SE, a defence equipment manufacturer, with trading set to begin on March 20.
Forge Investments Files SEC Document for Fund Series
Forge Investments filed a document for D - Fund FG-ORV under Section 3(c)(1) of the Investment Company Act on March 16, 2026, according to SEC EDGAR.
Forge Investments LLC Files for Fund FG-GRT Series
Forge Investments LLC filed a SEC document for its Fund FG-GRT series under Section 3(c)(7) on March 16, 2026.
PE-Backed Technimark Acquires Rage Custom Plastics
Technimark, a maker of injection-molded components, has acquired Rage Custom Plastics, as detailed in a PE Hub report.
BEDROCK TECH FUND LLC Files SEC Document on Investment Company Act
BEDROCK TECH FUND LLC submitted a SEC filing on March 16, 2026, citing Section 3(c)(1) of the Investment Company Act.
Gaingels Early Stage Fund II LLC Submits SEC Filing
Gaingels Early Stage Fund II LLC filed a document with the SEC on March 16, 2026, as recorded in the EDGAR database.
Bodney Fund I LP Files SEC Document Under Investment Company Act Section 3(c)(7)
D - Bodney Fund I LP submitted a filing to the SEC on March 13, 2026, related to Section 3(c)(7) of the Investment Company Act.
U.S. Boston Growth Capital QSBS Fund Files with SEC on March 13, 2026
D - U.S. Boston Growth Capital QSBS Fund, LP submitted a filing to the SEC, as recorded in the EDGAR database.
Domain Evergreen Onshore Fund, LP Files SEC Document
Domain Evergreen Onshore Fund, LP, with CIK 2060665, submitted a filing to the SEC on March 13, 2026.
A&Q Alternative Yield Fund Files Under Section 3(c)(7)
D/A - A&Q Alternative Yield Fund Ltd submitted a SEC filing on March 13, 2026, related to Section 3(c)(7) of the Investment Company Act.
Hiive SpaceX Opp Fund LLC Files Under Section 3(c)(7)
D - Hiive SpaceX Opp Fund LLC filed a document with the SEC on March 13, 2026, related to Section 3(c)(7) of the Investment Company Act.
Shakti Venture Capital Gatik, LLC Files Form D for Exempt Offering
Shakti Venture Capital Gatik, LLC submitted a Form D filing to the SEC on March 13, 2026, related to Section 3(c)(1) of the Investment Company Act.
Ardian, CVC, Verdane Eye Investments in Women’s Health; Exellere, GHO Exit Pathology Services Deal
Private equity firms Ardian, CVC, and Verdane target women’s health investments, while Exellere and GHO sell a pathology services company for $950 million.
D - Woven Equity Fund, LP Files SEC Document Under Section 3(c)(1)
D - Woven Equity Fund, LP submitted a filing to the SEC on March 12, 2026, related to Section 3(c)(1) of the Investment Company Act.
Survey Finds High-Net-Worth Women Investors Planning Venture Fund Investments
A Venture Capital Journal survey shows almost half of high-net-worth women investors are new to private markets, with 67% planning to invest $25k-$49k in venture funds this year.
American Power Fund I LP Files SEC Document
American Power Fund I LP, with CIK 2082121, submitted a filing to the SEC on March 12, 2026, according to EDGAR records.
D - 9038 21ST AVE SW PARTNERS, LLC Files SEC Document
D - 9038 21ST AVE SW PARTNERS, LLC submitted a filing to the SEC on March 12, 2026, as per regulatory records.
Griffin Capital DST Files Under Investment Company Act Section 3(c)(5)
Griffin Capital's DST entity in Kansas City, MO, filed a regulatory document with the SEC on March 12, 2026, citing Section 3(c)(5) of the Investment Company Act.
Reciprocal Ventures Files Under Investment Company Act Section 3(c)(1)
Reciprocal Ventures, a Series of Decile Start Fund, LP, filed a SEC EDGAR document on March 11, 2026, related to Section 3(c)(1) of the Investment Company Act.
Track Record and LP Alignment Key for Emerging Managers, per Churchill Expert
Buyouts Insider reports on the expanding ecosystem for emerging manager fundraising and Churchill Asset Management's role in supporting new firms.
Track Record and LP Alignment Key to Emerging Manager Success: Churchill's Anne Philpott
Buyouts Insider reports on the expansion of emerging manager fundraising and the role of firms like Churchill Asset Management in supporting new firm formation.
Axiom Partners Raises $52M for AI-Focused Debut Fund
Axiom Partners, founded by Khosla Ventures veteran Sandhya Venkatachalam, has closed its first seed-stage fund targeting AI companies addressing the 'capacity crunch'.
Anbec Partners Files Under Investment Company Act Section 3(c)(1)
Anbec Partners, LP submitted a SEC filing on March 10, 2026, related to Section 3(c)(1) of the Investment Company Act.
Cosmetic Physician Partners, LLC Files SEC Document
Cosmetic Physician Partners, LLC submitted a filing to the SEC on March 10, 2026, as recorded in EDGAR.
Pax VC Raises $50M for Debut Fund Led by Michelle Volz
Michelle Volz, formerly of Andreessen Horowitz, leads new firm Pax VC in raising $50 million for its first fund in just 12 months.
Pax VC Raises $50M for Debut Fund
Michelle Volz, formerly of Andreessen Horowitz, leads new firm Pax VC in raising $50 million for its first fund in 12 months.
SaddleRock Capital Cayman Fund Files Under Section 3(c)(7)
SaddleRock Capital Cayman Fund Ltd submitted a SEC filing on March 9, 2026, related to Investment Company Act exemptions.
Series B Funding Diversifies and Grows in 2026
Crunchbase data shows U.S. Series B funding increasing after 2023 lows, with diversified sectors and larger average round sizes in 2026.
Synergy Sports Capital Launches Targeting Lower Middle Market PE Deals
New private equity firm Synergy Sports Capital debuts with focus on lower middle market opportunities in sports industry.
Tim Draper Shares Insights on AI, Bitcoin and Innovation
Venture capitalist Tim Draper discusses AI trends, Bitcoin's future, and his startup initiatives in a recent interview with Crunchbase News.
Purpose Brands Expands Orangetheory Fitness in Japan via 10-Year Deal
Purpose Brands announces a 10-year renewal agreement with ITS Co., Ltd. to grow Orangetheory Fitness to over 100 studios in Japan by 2034.
Premier Graphene Advances Industrial Hemp Import Permits in Mexico
Premier Graphene Inc. announces its affiliate has progressed industrial hemp import permits and licensing, enabling operations in Mexico.
KALA BIO Announces AI Platform for Biotech and Pharma Sector
KALA BIO enters agreement with Younet AI to develop an on-premises AI infrastructure for secure biotech data analysis, addressing industry challenges.
JAKKS Pacific Renews Minecraft Costume Licensing Deal
Disguise, a division of JAKKS Pacific, extends its global licensing agreement for Minecraft costumes, building on the brand's growth amid recent media successes.
JAKKS Pacific and VIZ Media Partner on Naruto Toys and Costumes
JAKKS Pacific announces a licensing agreement with VIZ Media to produce Naruto action figures, playsets, and costumes for the US and Canada, set to debut in Spring 2027.
Hopewell Therapeutics Sublicenses LNPs to Foxcroft for Cancer Vaccine Development
Hopewell Therapeutics grants a global sublicense of its tissue-targeting LNPs to Foxcroft Therapeutics for novel cancer vaccines, including financial terms and planned collaborations.
Health Tech Companies Secure Major Funding Rounds
Several health tech firms including Talkiatry and Honest Health announced significant funding in February 2026 to expand operations and technology.
Candid Therapeutics Merges with Rallybio and Raises $505 Million
Candid Therapeutics announces a reverse merger with Rallybio and $505 million in private financing to advance its autoimmune drug pipeline.
Alpha Tau Medical Secures Japanese Approval for Alpha DaRT Cancer Therapy
Alpha Tau Medical receives first international regulatory approval for its Alpha DaRT device in Japan for head and neck cancer treatment.
Private Equity Distribution Pressures Create Market Division in 2026
New dynamics around DPI performance are splitting the private equity market as GPs face mounting pressure from LPs seeking distributions.
PE Fundraising Splits Between Cash Returners and Distribution Laggards
Private equity fundraising increasingly divided between GPs with strong DPI track records and those still holding unrealized gains.
OWS Capital Closes Second Offshore Fund Under 3(c)(7) Structure
OWS Capital files Form D for offshore Fund II, signaling completion of capital raising under Investment Company Act exemption.
